Literature DB >> 23581443

Reproduction of the Escherichia coli peritonitis syndrome in laying hens.

W J M Landman1, A Heuvelink, J H H van Eck.   

Abstract

In five experiments, each consisting of four or six groups with seven or 14 brown laying hens per group, birds were inoculated with an Escherichia coli strain, isolated from a layer with the E. coli peritonitis syndrome (EPS) by different routes between 23 and 33 weeks of age. Aerosol-exposed hens inhaled 10(5.1) to 10(6.2) colony-forming units per hen; hens inoculated by other routes received 10(7.6) to 10(9.1) colony-forming units per hen. In one experiment, one-half of the birds of each group were injected intraperitoneally with sterile egg yolk simultaneously with E. coli. Dead and surviving birds were necropsied and bacteriological examination of the bone marrow was performed. The percentage of birds with EPS that died was 89 (159/179). Nearly all dead birds showed septicaemia (155/159 = 97%), while most had septicaemia and peritonitis (126/159 = 79%). Surviving hens with EPS (20/179 = 11%) showed chronic peritonitis and inactive ovaries. Taking all experiments together, exposure of hens by the intravenous, intratracheal and intraperitoneal routes induced EPS in 84% (41/49), 80% (55/69) and 76% (16/21), respectively, while aerosol and intravaginal exposure resulted in EPS percentages of 57% (32/56) and 49% (28/57), respectively. Except for orally inoculated groups (7/56 = 13% EPS), in all other groups the EPS rates differed significantly (P <0.01) from those of the placebo-exposed groups (0/42). Neither the age of hens nor the presence of free yolk in the abdomen influenced the EPS rate. The results of the present study are suggestive of the respiratory and vaginal origin of EPS in the field.

Entities:  

Mesh:

Year:  2013        PMID: 23581443     DOI: 10.1080/03079457.2013.775694

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  7 in total

1.  Investigation of Serotype Prevalence of Escherichia coli Strains Isolated from Layer Poultry in Greece and Interactions with Other Infectious Agents.

Authors:  Dimitrios Koutsianos; Labrini V Athanasiou; Dimitris Mossialos; Giovanni Franzo; Mattia Cecchinato; Konstantinos C Koutoulis
Journal:  Vet Sci       Date:  2022-03-23

2.  Efficacy of an avian colibacillosis live vaccine for layer breeder in Japan.

Authors:  Yusuke Uotani; Rie Kitahara; Takahiko Imai; Nobuyuki Tsutsumi; Chihiro Sasakawa; Shinya Nagai; Tetsuji Nagano
Journal:  J Vet Med Sci       Date:  2017-06-11       Impact factor: 1.267

3.  Effects of age, weight, and housing system on prevalence of dead on arrival and carcass condemnation causes in laying hens.

Authors:  S Saraiva; C Saraiva; I Oliveira; G Stilwell; A Esteves
Journal:  Poult Sci       Date:  2020-12-10       Impact factor: 3.352

4.  Development of an aerogenous Escherichia coli infection model in adult broiler breeders.

Authors:  Sofie Kromann; Rikke Heidemann Olsen; Anders Miki Bojesen; Henrik Elvang Jensen; Ida Thøfner
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

5.  Tetratrichomonas gallinarum granuloma disease in a flock of free range layers.

Authors:  W J M Landman; N Gantois; J H H van Eck; H M J F van der Heijden; E Viscogliosi
Journal:  Vet Q       Date:  2019-12       Impact factor: 3.320

6.  Co-infection of Chicken Layers With Histomonas meleagridis and Avian Pathogenic Escherichia coli Is Associated With Dysbiosis, Cecal Colonization and Translocation of the Bacteria From the Gut Lumen.

Authors:  Mohamed Kamal Abdelhamid; Narciso M Quijada; Monika Dzieciol; Tamas Hatfaludi; Ivana Bilic; Evelyne Selberherr; Dieter Liebhart; Claudia Hess; Michael Hess; Surya Paudel
Journal:  Front Microbiol       Date:  2020-10-30       Impact factor: 5.640

7.  Comparison and assessment of necropsy lesions in end-of-lay laying hens from different housing systems in Denmark.

Authors:  Chong Wang; Susanne Elisabeth Pors; Jens Peter Christensen; Anders Miki Bojesen; Ida Thøfner
Journal:  Poult Sci       Date:  2019-12-30       Impact factor: 4.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.